Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-20

Clinical Trial Update: Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating PTNS plus mirabegron for refractory overactive bladder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)
  • posterior tibial nerve stimulation

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2023-07-20